Cases & Deals

Stentys completes €12.6 million rights issue

Clients Stentys

Jones Day advised Stentys, a French medical device company developing and commercializing innovative solutions for the treatment of patients with complex coronary artery disease, and Société Générale & Investment Banking, as lead manager and bookrunner, in connection with the €12.6 million (US$13.8 million) rights issue in a public offering in France and related private placement.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.